Appian is focusing on AI in processes. Clients like Pfizer and NASA demonstrate the benefits, but there are also limitations.
Converge Bio, the Generative AI Lab for the Life Sciences, shares findings from a new study showing that ConvergeABtm, their antibody design and optimization solution, was able to improve cetuximab, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results